Founding Year

2016

CEO

Branden RYU

Main Location

Boston, USA
Daejeon, Korea

Team members

86

(Ph.D. 25)

Total fundraising

78.5 million USD

Partners

Core technology

CNS targeted RNAi delivery system

Lead Program

BMD-001

(Neurodegenerative disease)

Achievements

  • Quick fire challenge award in Neuroscience, Johnson & Johnson Innovation
  • Endless Frontier Labs program graduation(US)

Certification

ISO 9001/13485
GMP Facility

Korea Venture Company

Last Updated: July, 2022